| scholarly article | Q13442814 |
| P50 | author | Alberto Mantovani | Q22069468 |
| P2093 | author name string | S Sozzani | |
| H A Weich | |||
| D Zhou | |||
| D Marmé | |||
| B Barleon | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vascular endothelial growth factor-activated receptor activity | Q14912386 |
| Fms related receptor tyrosine kinase 1 | Q21115605 | ||
| endothelium | Q111140 | ||
| cell migration | Q189092 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 3336-3343 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 | |
| P478 | volume | 87 |
| Q34334913 | A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network |
| Q38561314 | A placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism. |
| Q40392328 | A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration |
| Q37696351 | A review of clinical trials of anti-VEGF agents for diabetic retinopathy |
| Q28588739 | A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization |
| Q37164715 | AUF1-RGG peptides up-regulate the VEGF antagonist, soluble VEGF receptor-1 (sFlt-1). |
| Q39961630 | Activation of the VEGFR1 chromatin domain: an angiogenic signal-ETS1/HIF-2alpha regulatory axis |
| Q36186814 | Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery |
| Q92356780 | Acute exposure to low-level light at night is sufficient to induce neurological changes and depressive-like behavior |
| Q37106218 | Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma |
| Q36477682 | An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells |
| Q36616466 | An important role of blood and lymphatic vessels in inflammation and allergy |
| Q54600800 | Analysis of placental growth factor in placentas of normal pregnant women and women with hypertensive disorders of pregnancy. |
| Q24316017 | Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma |
| Q35194484 | Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation |
| Q34075013 | Angiogenesis and chronic kidney disease |
| Q34109028 | Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. |
| Q37645436 | Angiogenesis in the atherosclerotic plaque. |
| Q36346473 | Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). |
| Q55344494 | Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction. |
| Q34121752 | Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide. |
| Q33793109 | Anti-vascular endothelial growth factor acts on retinal microglia/macrophage activation in a rat model of ocular inflammation |
| Q42402968 | Antiangiogenesis therapy in the treatment of metastatic colorectal cancer |
| Q41403094 | Antiangiogenic Therapy for Diabetic Nephropathy |
| Q38264310 | Antiangiogenic therapies for glioblastoma |
| Q34145245 | Antiangiogenic therapy for glioblastoma |
| Q28538183 | Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes |
| Q37462742 | Anticancer effects of the engineered stem cells transduced with therapeutic genes via a selective tumor tropism caused by vascular endothelial growth factor toward HeLa cervical cancer cells |
| Q38185490 | Basophils and skin disorders |
| Q89669447 | Blood-brain barrier development: Systems modeling and predictive toxicology |
| Q43755773 | Blood-retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains |
| Q83699933 | Bone marrow angiogenesis and progression in multiple myeloma |
| Q37622043 | Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization |
| Q36085110 | CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice |
| Q92626377 | Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice |
| Q35603983 | Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis |
| Q34143870 | Characterization of adipose-derived stem cells of anatomical region from mice |
| Q38341686 | Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase). |
| Q35949632 | Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling |
| Q38806366 | Concise Review: Organ Engineering: Design, Technology, and Integration. |
| Q35960196 | Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets |
| Q36433516 | Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue |
| Q38590032 | Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits |
| Q34803171 | Critical appraisal of ranibizumab in the treatment of diabetic macular edema |
| Q35166644 | Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. |
| Q36089540 | Critical role of microenvironmental factors in angiogenesis |
| Q37801912 | Current approaches to the management of diabetic retinopathy and diabetic macular oedema |
| Q36392576 | Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production. |
| Q28728219 | Deguelin attenuates reperfusion injury and improves outcome after orthotopic lung transplantation in the rat |
| Q33638148 | Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury |
| Q35031955 | Dietary fish oil improves endothelial function and lowers blood pressure via suppression of sphingolipid-mediated contractions in spontaneously hypertensive rats. |
| Q30488864 | Dimerization of VEGF receptors and implications for signal transduction: a computational study |
| Q35791487 | Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis |
| Q24303123 | Drusen complement components C3a and C5a promote choroidal neovascularization |
| Q41221924 | Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis |
| Q34474545 | Effect of intravitreal bevacizumab on vascular endothelial growth factor expression in patients with proliferative diabetic retinopathy |
| Q35215426 | Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo. |
| Q35557415 | Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model |
| Q37694918 | Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors |
| Q45867350 | Endogenous expression of angiogenesis-related factors in response to muscle injury |
| Q33250101 | Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro |
| Q42554370 | Enhanced vascular endothelial growth factor gene expression in ischaemic skin of critical limb ischaemia patients |
| Q37786019 | Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions. |
| Q92622334 | Epidermal autonomous VEGFA/Flt1/Nrp1 functions mediate psoriasis-like disease |
| Q35015402 | Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes |
| Q36950613 | Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalus |
| Q37157213 | Exercise training and peripheral arterial disease |
| Q38362800 | Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses |
| Q35786262 | Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs |
| Q36474296 | Expression of HIF-2alpha/EPAS1 in hepatocellular carcinoma |
| Q35087770 | Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali |
| Q35788966 | Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration |
| Q74261271 | Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA) |
| Q92002839 | FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD) |
| Q42067795 | Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice |
| Q36992647 | Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway |
| Q28504776 | Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice |
| Q51569218 | GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. |
| Q28595005 | Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation |
| Q35023822 | Gender differences in cardiovascular disease: hormonal and biochemical influences. |
| Q37467891 | Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. |
| Q95267554 | Gene-activated dermal equivalents to accelerate healing of diabetic chronic wounds by regulating inflammation and promoting angiogenesis |
| Q28389691 | Generation and biological activities of oxidized phospholipids |
| Q37076616 | Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature |
| Q38007880 | HIF-mediated endothelial response during cancer progression. |
| Q24795592 | Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis |
| Q37515852 | How vascular endothelial growth factor-A (VEGF) regulates differentiation of mesenchymal stem cells |
| Q60647750 | Human IgG1 antibodies suppress angiogenesis in a target-independent manner |
| Q39652186 | Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor |
| Q33849065 | Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects |
| Q34009606 | Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. |
| Q28766797 | Hypertension and maternal-fetal conflict during placental malaria |
| Q43763757 | Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma |
| Q33809268 | Hypoxia potentiates glioma-mediated immunosuppression |
| Q36193194 | Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans |
| Q48128395 | Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1. |
| Q41401879 | Immune effects of bevacizumab: killing two birds with one stone |
| Q35113731 | Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis |
| Q47251342 | Immunolocalization of vascular endothelial growth factor in rat condylar cartilage during postnatal development |
| Q37748469 | Immunologic mechanisms in RCC and allogeneic renal transplant rejection. |
| Q37109989 | Immunological mechanisms in the pathogenesis of diabetic retinopathy |
| Q50055217 | Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa |
| Q47138737 | Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib |
| Q44880009 | Increased placental growth factor in cerebrospinal fluid of patients with epilepsy |
| Q37792817 | Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications |
| Q34960144 | Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis |
| Q33832620 | Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor |
| Q46099636 | Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis |
| Q28572517 | Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia |
| Q48216065 | Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor |
| Q55427105 | Intravitreal Bevacizumab Injection Attenuates Diabetic Retinopathy in Adult Rats with Experimentally Induced Diabetes in the Early Stage. |
| Q39812192 | Intravitreal ranibizumab in treating extensive traumatic submacular hemorrhage |
| Q34558137 | Investigating the antiproliferative activity of high affinity DNA aptamer on cancer cells |
| Q35145097 | Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia |
| Q33577410 | Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes β cell regeneration |
| Q46894342 | It Takes Two to Tango: Coupling of Angiogenesis and Osteogenesis for Bone Regeneration. |
| Q38008362 | Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation |
| Q33897202 | Kinase inhibitors in cancer therapy: a look ahead |
| Q54545150 | Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children. |
| Q64097376 | Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway |
| Q34144848 | Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage |
| Q92577677 | Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors |
| Q29547620 | Macrophage plasticity and polarization: in vivo veritas |
| Q36838542 | Macrophages define the invasive microenvironment in breast cancer |
| Q64967887 | Macrophages of distinct origins contribute to tumor development in the lung. |
| Q64990427 | Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. |
| Q92558180 | Maternal Flt-1 and endoglin expression by circulating monocyte subtype and polarization in preeclampsia and fetal growth restriction |
| Q35855488 | Mathematical modeling of tumor-induced angiogenesis |
| Q42121256 | Mathematical modeling predicts synergistic antitumor effects of combining a macrophage-based, hypoxia-targeted gene therapy with chemotherapy |
| Q90005073 | Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells |
| Q41570171 | Microenvironment-centred dynamics in aggressive B-cell lymphomas |
| Q50607022 | Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology. |
| Q37100566 | Migratory neighbors and distant invaders: tumor-associated niche cells |
| Q33376945 | Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. |
| Q34566028 | Molecular and functional diversity of vascular endothelial growth factors |
| Q30443135 | Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia |
| Q36296789 | Molecular pathogenesis of retinal and choroidal vascular diseases |
| Q55473747 | Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft. |
| Q92446218 | Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis |
| Q37672891 | Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice |
| Q34329152 | Multiple myeloma macrophages: pivotal players in the tumor microenvironment. |
| Q41645290 | Multiple roles for VEGF in non-melanoma skin cancer: angiogenesis and beyond |
| Q36627580 | Myeloid cell trafficking and tumor angiogenesis |
| Q37758250 | Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation. |
| Q35554334 | Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis |
| Q35949620 | Myocardial angiogenesis |
| Q93387980 | Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD |
| Q33876274 | Neuropeptide substance P improves osteoblastic and angiogenic differentiation capacity of bone marrow stem cells in vitro |
| Q37138903 | Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity |
| Q92344153 | New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma |
| Q40927994 | New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance. |
| Q33689928 | Notch regulates the angiogenic response via induction of VEGFR-1. |
| Q37460657 | Notch1 Deficiency Results in Decreased Inflammation during Wound Healing and Regulates Vascular Endothelial Growth Factor Receptor-1 and Inflammatory Cytokine Expression in Macrophages |
| Q35085430 | Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes |
| Q35830419 | Nucleoside Reverse Transcriptase Inhibitors Suppress Laser-Induced Choroidal Neovascularization in Mice |
| Q38074872 | Ocular neovascularization |
| Q36515058 | Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair |
| Q36255954 | Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. |
| Q53647598 | Overexpression of VEGF183 promotes murine breast cancer cell proliferation in vitro and induces dilated intratumoral microvessels. |
| Q41769649 | Overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in sacral giant cell tumors and the correlation with tumor microvessel density |
| Q36220799 | Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate |
| Q37986561 | Patients with metastatic breast cancer using bevacizumab as a treatment: is there still a role for it? |
| Q24805783 | Peripheral monocytes from diabetic patients with coronary artery disease display increased bFGF and VEGF mRNA expression |
| Q73293875 | Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid |
| Q40979859 | Placenta growth factor (PlGF) mRNA expression in brain tumors |
| Q36246209 | Placenta growth factor and vascular endothelial growth factor a have differential, cell-type specific patterns of expression in vascular cells |
| Q43164474 | Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair |
| Q37426670 | Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment |
| Q34207424 | Plaque angiogenesis and atherosclerosis |
| Q35087922 | Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair |
| Q39265508 | Positive correlation between PEDF expression levels and macrophage density in the human prostate |
| Q35839346 | Post-radiation increase in VEGF enhances glioma cell motility in vitro |
| Q34478521 | Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability |
| Q37467898 | Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of respiratory syncytial virus infection |
| Q35183529 | Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma |
| Q40271475 | Proinflammatory functions of vascular endothelial growth factor in alloimmunity |
| Q36050692 | Properties of mechano-transduction via simulated microgravity and its effects on intracellular trafficking of VEGFR's |
| Q39611324 | RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway |
| Q42263637 | RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy |
| Q33735558 | Regulation of angiogenesis by histone chaperone HIRA-mediated incorporation of lysine 56-acetylated histone H3.3 at chromatin domains of endothelial genes |
| Q24564308 | Regulation of inflammation in cancer by eicosanoids |
| Q33605750 | Regulation of scar formation by vascular endothelial growth factor |
| Q37094060 | Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward? |
| Q36292232 | Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. |
| Q89823984 | Research Progress on Tumor-Associated Macrophages and Inflammation in Cervical Cancer |
| Q35621292 | Research progress of vasculopathy in portal hypertension |
| Q42367664 | Reversible retinal vessel closure from VEGF-induced leukocyte plugging |
| Q35971694 | Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions |
| Q36284948 | Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes |
| Q37470198 | Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling |
| Q41443989 | Role of the VEGF-Flt-1-FAK pathway in the pathogenesis of osteoclastic bone destruction of giant cell tumors of bone |
| Q35300661 | Role of vascular permeability factor/vascular endothelial growth factor in eye disease |
| Q36248647 | Roles for VEGF in the adult. |
| Q47116461 | Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma. |
| Q42045011 | Selective stimulation of VEGFR2 accelerates progressive renal disease |
| Q40804521 | Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. |
| Q90277706 | Shear stress promotes differentiation of stem cells from human exfoliated deciduous teeth into endothelial cells via the downstream pathway of VEGF-Notch signaling |
| Q39559510 | Soluble vascular endothelial growth factor (VEGF) receptor-1 inhibits migration of human monocytic THP-1 cells in response to VEGF. |
| Q36014739 | Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier |
| Q37463897 | Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis. |
| Q34656053 | Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization |
| Q44393845 | Stromal cell-derived factor 1alpha (SDF-1alpha) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation |
| Q92727693 | Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation |
| Q41840233 | Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype |
| Q30438979 | Systems biology of vascular endothelial growth factors |
| Q34040956 | Targeted inhibition of VEGF receptor 2: an update on ramucirumab |
| Q36890872 | Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain |
| Q26852762 | Targeting the intragraft microenvironment and the development of chronic allograft rejection |
| Q37767356 | Targeting the tumour vasculature: insights from physiological angiogenesis |
| Q36508627 | Targeting vasculature in urologic tumors: mechanistic and therapeutic significance |
| Q36377797 | Temporal phenotypic features distinguish polarized macrophages in vitro |
| Q30488952 | The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12. |
| Q35680577 | The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia |
| Q24532025 | The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells |
| Q33733437 | The VEGF family in cancer and antibody-based strategies for their inhibition |
| Q41354182 | The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes |
| Q51430093 | The impact of vascular endothelial growth factor +405 C/G polymorphism on long-term outcome and severity of coronary artery disease. |
| Q38945564 | The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®). |
| Q35223952 | The link between major histocompatibility complex antibodies and cell proliferation |
| Q38008966 | The molecular profile of microglia under the influence of glioma |
| Q36390431 | The role of VEGF receptors in angiogenesis; complex partnerships |
| Q31061150 | The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment |
| Q37308157 | The role of vascular endothelial growth factor in wound healing |
| Q38880066 | The roles of vascular endothelial growth factor in bone repair and regeneration |
| Q41077200 | The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade |
| Q37431272 | The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease |
| Q37820210 | The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease |
| Q30496577 | Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction |
| Q47644157 | Tobacco exposure and wound healing in head and neck surgical wounds. |
| Q36401529 | Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation |
| Q42031076 | Transplantable subcutaneous hepatoma 22a affects functional activity of resident tissue macrophages in periphery |
| Q92342583 | Traumatic submacular hemorrhage: available treatment options and synthesis of the literature |
| Q34217612 | Treatment of mouse limb ischemia with an integrative hypoxia-responsive vector expressing the vascular endothelial growth factor gene. |
| Q92621653 | Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis |
| Q35838122 | Tumor lymphangiogenesis as a potential therapeutic target |
| Q38766176 | Tumor-associated macrophages and anti-tumor therapies: complex links |
| Q39100693 | Tumour-associated macrophages as treatment targets in oncology. |
| Q34114488 | Two cases of breast carcinoma with osteoclastic giant cells: are the osteoclastic giant cells pro-tumoural differentiation of macrophages? |
| Q36083881 | Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex |
| Q51909063 | Unexplained fetal death: another anti-angiogenic state. |
| Q38657877 | Upregulation of hypoxia-inducible factor 1 alpha in local vein wall is associated with enhanced venous thrombus resolution. |
| Q43110034 | VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population. |
| Q42099822 | VEGF and Notch in tip and stalk cell selection |
| Q41988055 | VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling |
| Q92229613 | VEGF in Signaling and Disease: Beyond Discovery and Development |
| Q50025011 | VEGF may contribute to macrophage recruitment and M2 polarization in the decidua. |
| Q35448592 | VEGF polymorphisms and severity of atherosclerosis. |
| Q34048015 | VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice |
| Q39249401 | VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult |
| Q34972337 | VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV. |
| Q37795572 | VEGF receptor signaling in vertebrate development. |
| Q40725945 | VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment |
| Q36684948 | VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients |
| Q37606226 | VEGF-VEGFR Signals in Health and Disease |
| Q36371399 | VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. |
| Q79221681 | VEGF165 therapy exacerbates secondary damage following spinal cord injury |
| Q37197494 | VEGFR and type-V RTK activation and signaling |
| Q34097471 | VEGFR1-positive macrophages facilitate liver repair and sinusoidal reconstruction after hepatic ischemia/reperfusion injury |
| Q27023354 | Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair |
| Q77947763 | Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes |
| Q35689605 | Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? |
| Q34101611 | Vascular endothelial growth factor 165b expression in stromal cells and colorectal cancer |
| Q28506172 | Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos |
| Q26777347 | Vascular endothelial growth factor A: just one of multiple mechanisms for sex-specific vascular development within the testis? |
| Q24679724 | Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells |
| Q40438351 | Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone |
| Q36369295 | Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. |
| Q33804469 | Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response |
| Q41772601 | Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption |
| Q38983079 | Vascular endothelial growth factor control mechanisms in skeletal growth and repair |
| Q54505598 | Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. |
| Q41892349 | Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage |
| Q37158665 | Vascular endothelial growth factor of the lung: friend or foe |
| Q37726957 | Vascular endothelial growth factor promotes fibrosis resolution and repair in mice |
| Q40281928 | Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases |
| Q36676685 | Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages |
| Q35747351 | Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts |
| Q42280089 | Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis |
| Q35921437 | Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis |
| Q28345309 | Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype |
| Q37929573 | Vascular growth in health and disease |
| Q37110304 | Vascular remodeling is airway generation-specific in a primate model of chronic asthma |
| Q53930051 | [Vascular endothelial factor (VEGF): therapeutic angiogenesis and vasculogenesis in the treatment of cardiovascular disease] |
Search more.